GlassScriptPhysician profile
Glenn S Hamroff
NPI 1720081318
$162,121.21
in general payments reported to CMS, 2019-2025
42 companies · $2,637 in 2025
The $2,637 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66K · 2020: $9,030 · 2021: $32K · 2022: $19K · 2023: $17K · 2024: $17K · 2025: $2,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $8,569 · Travel and Lodging: $1,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,498.50 |
| Food and Beverage | $8,568.90 |
| Travel and Lodging | $1,984.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $97,103.78 | 2019-2024 | Xarelto |
| Amgen INC. | $21,416.72 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $14,575.47 | 2019-2025 | |
| Novo Nordisk INC | $8,169.55 | 2019-2024 | Ozempic |
| Boston Scientific Corporation | $4,214.75 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Portola Pharmaceuticals, LLC | $2,476.32 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,175.52 | 2019-2024 | Jardiance |
| Janssen Research & Development, LLC | $1,882.17 | 2023 | |
| Abbott Laboratories | $1,834.15 | 2019-2025 | Jot Dx, Cardiomems, Mitraclip |
| Medtronic, INC. | $1,193.75 | 2021-2025 | Micra, Onyx Frontier, Linq II |
| Merck Sharp & Dohme LLC | $1,093.51 | 2022-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $1,034.62 | 2019-2024 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $487.55 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $432.32 | 2019-2023 | Camzyos |
| Genzyme Corporation | $346.18 | 2019-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $335.10 | 2019-2020 | |
| Pfizer INC. | $322.62 | 2019-2021 | |
| Medtronic Vascular, INC. | $312.93 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $278.05 | 2019-2023 | Xarelto |
| Heartflow, INC. | $275.37 | 2025 | |
| Edwards Lifesciences Corporation | $242.10 | 2019-2024 | |
| Beta Bionics, INC. | $166.50 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Daiichi Sankyo INC. | $162.92 | 2019-2021 | |
| Inspire Medical Systems, INC. | $153.72 | 2024 | Inspire |
| Bridgebio Pharma, INC. | $145.62 | 2025 | Attruby |
| Abiomed | $143.38 | 2023 | Impella |
| Akcea Therapeutics, INC. | $137.55 | 2019-2021 | |
| Irhythm Technologies, INC. | $137.13 | 2020 | |
| Shockwave Medical, INC | $134.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $111.05 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $109.34 | 2019 | |
| Lundbeck LLC | $105.22 | 2019-2020 | |
| Esperion Therapeutics, INC. | $85.39 | 2020 | |
| Atricure, INC. | $77.59 | 2023 | |
| Gilead Sciences, INC. | $70.21 | 2019 | |
| Lantheus Medical Imaging, INC. | $53.57 | 2019 | |
| Biotronik INC. | $40.75 | 2019-2020 | |
| Medicomp INC | $37.48 | 2023 | Telepatch Cardiac Monitor |
| Scpharmaceuticals INC. | $16.29 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.23 | 2023 | |
| Sanofi-Aventis U.S. LLC | $13.97 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Hamroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.